IOBENGUANE: 28 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
28
Total FAERS Reports
7 (25.0%)
Deaths Reported
13
Hospitalizations
28
As Primary/Secondary Suspect
1
Disabilities
First Report: 20140817 · Latest Report: 20140817
What Are the Most Common IOBENGUANE Side Effects?
#1 Most Reported
Neutropenia
12 reports (42.9%)
#2 Most Reported
Mucosal inflammation
12 reports (42.9%)
#3 Most Reported
Febrile neutropenia
9 reports (32.1%)
All IOBENGUANE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Mucosal inflammation | 12 | 42.9% | 1 | 6 |
| Neutropenia | 12 | 42.9% | 0 | 12 |
| Febrile neutropenia | 9 | 32.1% | 5 | 3 |
| Haematotoxicity | 7 | 25.0% | 1 | 0 |
| Bk virus infection | 6 | 21.4% | 5 | 0 |
| Cytomegalovirus infection | 6 | 21.4% | 5 | 0 |
| Disease progression | 6 | 21.4% | 4 | 0 |
| Graft versus host disease | 6 | 21.4% | 5 | 0 |
Who Reports IOBENGUANE Side Effects? Age & Gender Data
Gender: 61.5% female, 38.5% male. Average age: 6.3 years. Most reports from: IT. View detailed demographics →
Is IOBENGUANE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2014 | 1 | 0 | 1 |
What Is IOBENGUANE Used For?
| Indication | Reports |
|---|---|
| Neuroblastoma | 21 |
| Neuroblastoma recurrent | 7 |
Official FDA Label for IOBENGUANE
Official prescribing information from the FDA-approved drug label.